Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis (MS)

Explore clinical trials studying Multiple Sclerosis (MS). Study availability and eligibility vary by location and protocol.

50 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis (MS) trial results

Completed

Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis

NCT04777539

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Strasbourg University Hospital Strasbourg, Bas-Rhin, France
  • Marseille University Hospital Marseille, Bouches-du-Rhône, France
  • Brest University Hospital Brest, Finistère, France
  • Bordeaux University Hospital Bordeaux, Gironde, France
View all 21 locations
View Trial Details
Completed

A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis

NCT03972306

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • The NeuroMedical Clinic of Central Louisiana Alexandria, Louisiana, United States
  • Ochsner Clinic Foundation New Orleans, Louisiana, United States
View all 18 locations
View Trial Details
Completed

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

NCT04602390

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +7 more
Locations
  • North Central Neurology Cullman, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • UC Health Neurosciences Center Aurora, Colorado, United States
  • Aqualane Clinical Research Naples, Florida, United States
View all 15 locations
View Trial Details
Completed

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

NCT03737851

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • University of Alabama at Birmingham - Main /ID# 204618 Birmingham, Alabama, United States
  • St. Josephs Hospital and Med Center /ID# 204197 Phoenix, Arizona, United States
  • Sutter East Bay Medical Foundation-Jordon Research and Education Dev. Inst. /ID# 204249 Berkeley, California, United States
  • The Research Center of Southern California /ID# 204269 Carlsbad, California, United States
View all 49 locations
View Trial Details
Completed

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis

NCT03737812

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • St. Josephs Hospital and Med Center /ID# 202809 Phoenix, Arizona, United States
  • Sutter East Bay Medical Foundation-Jordon Research and Education Dev. Inst. /ID# 202448 Berkeley, California, United States
  • The Research Center of Southern California /ID# 202802 Carlsbad, California, United States
  • Vladimir Royter MD /ID# 202483 Hanford, California, United States
View all 37 locations
View Trial Details

Related conditions